Investor Presentaiton
FY2023 Separation Roadmap
■ Separation of CMS/C&I for FY23
would result in 150bps margin uplift
Impact before any further benefit
from Cost Optimization Plan
FY2023
CMS/C&I
Actual
Separation
FY2023
Adjusted
Adj. Net Revenue*
$13,301
($5,438)
$7,863
Adj. EBITDA*
Margin %
1,436
(465)
971
10.8%
8.6%
12.3%
(+150 bps)
*See Non-GAAP reconciliation and operating metrics at the end of presentation
16
CMS/C&I Financials
Revenues of $5,438M composed of CMS segment revenue of $4,694M plus net
revenue from the portion of DVS included in the separation of $744M ($807M gross
revenue)
Adjusted EBITDA margin of 7.7% (as disclosed in transaction presentation) included:
Estimated $10M in incremental standalone costs
Estimated $30M in unallocated Jacobs corporate costs that support
CMS/C&I business
Figures are based on preliminary unaudited information and may not be reflective of Carve-Out Financial Statements prepared in accordance with
US GAAP.
Jacobs 2023View entire presentation